Max, CHOC patient with acute lymphoblastic leukemia (ALL), participates in cancer research trials to improve outcomes and treatments.
Working to improve leukemia outcomes with advanced research
Physicians at CHOC lead a new study to improve survival rates of children with pediatric acute lymphoblastic leukemia (ALL).
Leukemia stopped her in her tracks, but not her willingness to participate in oncology studies
A CHOC AYA oncology patient uses her experience to give back to others by participating in ongoing cancer research and clinical trials.
First batch of awardees announced for new Chief Scientific Officer small grant program
Research projects of the winners – 12 of 23 were awarded funding – range from virtual reality training to the use of AI to predict COVID-19.
The forefront of CAR T-Cell immunotherapy research for high-risk pediatric leukemia patients
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.
Premier CHOC leukemia and immunotherapy conference draws international experts
Attendees of the 2018 Society of Young Adult Oncology/CHOC Leukemia Symposium shared the latest advances in acute leukemia treatment.
